Overview

First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study

Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum
Phase:
N/A
Details
Lead Sponsor:
King Faisal Specialist Hospital & Research Center
Treatments:
Bevacizumab